Tom Seaver, like Robin Williams, had Lewy body dementia, but what is this strange illness?
In The Conversation, Dr. Melissa Armstrong discusses Lewy body dementia, the second most common degenerative dementia.
All Posts
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.
Study examines differences in people of diverse backgrounds with Lewy body disease
New study led by Dr. Melissa Armstrong and Andrea Kurasz published in the Journal of Alzheimer’s Disease.
UF neurologists create a new image of Parkinson disease
New, more diverse image better represents who is affected by Parkinson disease, and how.
New study shows common diabetes drug improves symptoms in genetic form of ALS in mice
New preclinical research shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.
Life after a neural implant trial
In a Nature Medicine news feature, Dr. Michael Okun discusses the challenges that follow some neural implant trials.
The link between Parkinson’s disease and toxic chemicals
New York Times article exploring possible link between some cases of Parkinson’s and exposure to toxic chemicals cites expertise of Dr. Michael Okun.
Investigators earn Michael J. Fox Foundation award
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
Preparing a person with Parkinson’s for a hospital stay
Dr. Michael Okun discusses why it's important for patients with Parkinson's disease to alert their hospital caretakers.
UF-led Alzheimer’s research consortium awarded $15 million
New grant will enable 1 Florida ADRC to continue its work with a bolstered focus on advancing understanding of dementias in diverse populations.
